Search

Search Constraints

You searched for: Author/Creator Jacoby, David

Search Results

1. Disease characteristics and progression in patients with late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease: an observational cohort study. (August 2018)

2. Neurofilament light is a treatment‐responsive biomarker in CLN2 disease. Issue 12 (8th December 2019)

7. Clinical Pharmacokinetics and Pharmacodynamics of Cerliponase Alfa, Enzyme Replacement Therapy for CLN2 Disease by Intracerebroventricular Administration. Issue 2 (30th November 2020)

8. Disease characteristics and progression in patients with late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2) disease: an observational cohort study. (August 2018)

9. Epigenetic therapy for Friedreich ataxia. Issue 4 (16th September 2014)